KP Tissue Inc is seeing a rise in its stock price, reflecting positive market sentiment.
KP Tissue Inc (KPT.TO) shares are up 1.15% today, reaching CA$11.39. This increase comes as the company shows resilience in its financial performance, especially after its recent quarterly results.
Advertisement
KP Tissue Inc
KPT.TO
KPT.TO
KP Tissue Inc
WealthAwesomeMarket cap
$112.96M
P/E
12.8x
Div. yield
5.92%
Div. / share
$0.72
52W high
$13.39
52W low
$8.54
1W change
-12.85%
Beta
0.39
Analyst Price Targets
Based on analyst covering KPT · as of Sep 17, 2026
Wall Street analysts forecast KPT stock price to rise 16.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$13.13
+16.6% Upside
Current Price
C$11.26
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on KPT's historical volatility
30-Day Vol
25.6%
Annualized
90-Day Vol
20.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$9.42
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$10.61 | C$9.71 – C$11.59 |
| 60 trading days | C$10.00 | C$8.82 – C$11.32 |
| 90 trading days | C$9.42 | C$8.08 – C$10.97 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may find KP Tissue Inc attractive due to its steady revenue growth and commitment to returning value through dividends.
KP Tissue Inc's Market Cap Reaches CA$112.96 Million
With a market cap of CA$112.96 million and a P/E ratio of 12.94, KP Tissue Inc appears to be a potentially undervalued stock.
Bull case
The latest financial results show a solid revenue increase and improved EBITDA, which could draw in more investors seeking stable growth.
Bear case
Despite the positive trend, the company’s profit margin remains at 0%, raising concerns about its long-term profitability.
Recent Financial Performance
Advertisement
KP Tissue Inc recently reported a 2.8% revenue increase for Q2 2026, reaching CA$550.9 million, along with a significant 25.0% rise in adjusted EBITDA to CA$90.6 million. These results highlight the company's ability to grow in a competitive market, likely contributing to the stock's positive movement today.
Dividend Declaration
The company has declared a quarterly dividend of CA$0.21 per common share, payable on July 15, 2026. This commitment to returning value to shareholders may boost investor confidence and support the stock's upward trend.
Market Outlook
As KP Tissue Inc continues to show revenue growth and maintain shareholder returns, investors will be closely watching to see if the company can improve its profit margins and overall profitability in the coming quarters. For more details on the stock's performance, check out the KP Tissue Inc stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
